Anaptysbio (ANAB) Operating Leases (2016 - 2025)
Historic Operating Leases for Anaptysbio (ANAB) over the last 5 years, with Q3 2025 value amounting to $14.6 million.
- Anaptysbio's Operating Leases fell 1144.66% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year decrease of 1144.66%. This contributed to the annual value of $14.1 million for FY2024, which is 1200.35% down from last year.
- Latest data reveals that Anaptysbio reported Operating Leases of $14.6 million as of Q3 2025, which was down 1144.66% from $15.1 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Operating Leases registered a high of $20.9 million during Q3 2021, and its lowest value of $14.1 million during Q4 2024.
- Over the past 5 years, Anaptysbio's median Operating Leases value was $18.0 million (recorded in 2022), while the average stood at $17.9 million.
- In the last 5 years, Anaptysbio's Operating Leases tumbled by 267.12% in 2022 and then crashed by 1200.35% in 2024.
- Over the past 5 years, Anaptysbio's Operating Leases (Quarter) stood at $19.4 million in 2021, then decreased by 8.42% to $17.8 million in 2022, then dropped by 9.97% to $16.0 million in 2023, then dropped by 12.0% to $14.1 million in 2024, then increased by 3.5% to $14.6 million in 2025.
- Its Operating Leases was $14.6 million in Q3 2025, compared to $15.1 million in Q2 2025 and $15.6 million in Q1 2025.